DermTech, Inc.
DMTKQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$3496
P/E Ratio—
52W High$0.059
52W Low$0.00001
DermTech, Inc. (DMTKQ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DMTKQ · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 29, 2024EPS Actual
-$0.52
Est. -$0.52 · +0.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 29, 2024
After Market Close
🔥 4-Quarter EPS Beat Streak
DMTKQ reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Jun 5, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 22, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Feb 26, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 14, 2024 | -$0.52 | — | — | — | — | — |
| — Q3 FY2024 | Aug 29, 2024 | -$0.52 | -$0.52 | +0.0% | — | $0.00B | — |
| ▲ Q2 FY2024 | May 14, 2024 | -$0.62 | -$0.58 | +6.5% | $0.00B | $0.00B | -2.3% |
| ▲ Q1 FY2024 | Feb 29, 2024 | -$0.57 | -$0.56 | +1.6% | $0.00B | $0.00B | -2.9% |
| ▲ Q4 FY2023 | Nov 2, 2023 | -$0.76 | -$0.57 | +25.9% | $0.00B | $0.00B | +0.3% |
Q2 FY2025
Jun 5, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 22, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 14, 2024
EPS Actual
—
EPS Est.
-$0.52
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.52
EPS Est.
-$0.52
EPS Surpr.
+0.0%
Revenue
—
Q2 FY2024
May 14, 2024Beat
EPS Actual
-$0.58
EPS Est.
-$0.62
EPS Surpr.
+6.5%
Revenue
$0.00B
Q1 FY2024
Feb 29, 2024Beat
EPS Actual
-$0.56
EPS Est.
-$0.57
EPS Surpr.
+1.6%
Revenue
$0.00B
Q4 FY2023
Nov 2, 2023Beat
EPS Actual
-$0.57
EPS Est.
-$0.76
EPS Surpr.
+25.9%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q3 FY2026 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q2 FY2026 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q1 FY2026 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q4 FY2025 | $-0.51 | $-0.51 | $-0.51 | 1 |
| Q3 FY2025 | $-0.52 | $-0.52 | $-0.52 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2024 | Aug 29, 2024 | +0.0% | $0.04 | $0.04 | -12.05% |
| ▲ Q2 FY2024 | May 14, 2024 | +6.5% | $0.62 | $0.64 | +2.90% |
| ▲ Q1 FY2024 | Feb 29, 2024 | +1.6% | $1.33 | $1.28 | -3.76% |
| ▲ Q4 FY2023 | Nov 2, 2023 | +25.9% | $1.38 | $1.40 | +1.45% |
| ▼ Q3 FY2023 | Aug 3, 2023 | -1.4% | $3.00 | $3.13 | +4.33% |
| ▼ Q2 FY2023 | May 4, 2023 | -12.0% | $2.93 | $3.15 | +7.51% |
| ▲ Q1 FY2023 | Mar 2, 2023 | +3.1% | $4.12 | $3.80 | -7.77% |
| ▲ Q4 FY2022 | Nov 3, 2022 | +3.4% | $3.06 | $3.00 | -1.96% |
Q3 FY2024-12.05%
Report Date
Aug 29, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.04
Price After
$0.04
Q2 FY2024+2.90%
Report Date
May 14, 2024
EPS Beat/Miss
+6.5%
Price Before
$0.62
Price After
$0.64
Q1 FY2024-3.76%
Report Date
Feb 29, 2024
EPS Beat/Miss
+1.6%
Price Before
$1.33
Price After
$1.28
Q4 FY2023+1.45%
Report Date
Nov 2, 2023
EPS Beat/Miss
+25.9%
Price Before
$1.38
Price After
$1.40
Q3 FY2023+4.33%
Report Date
Aug 3, 2023
EPS Beat/Miss
-1.4%
Price Before
$3.00
Price After
$3.13
Q2 FY2023+7.51%
Report Date
May 4, 2023
EPS Beat/Miss
-12.0%
Price Before
$2.93
Price After
$3.15
Q1 FY2023-7.77%
Report Date
Mar 2, 2023
EPS Beat/Miss
+3.1%
Price Before
$4.12
Price After
$3.80
Q4 FY2022-1.96%
Report Date
Nov 3, 2022
EPS Beat/Miss
+3.4%
Price Before
$3.06
Price After
$3.00
Avg Beat Reaction-3.53%
Avg Miss Reaction+5.92%
Beat Rate6 / 8 quarters
Largest Move-12.05% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DMTKQ ends December
DermTech, Inc. (DMTKQ) most recently reported earnings on August 29, 2024 for Q3 FY2024, posting EPS of $-0.52 (in line with the analyst consensus of $-0.52). DMTKQ has beaten EPS estimates for 4 consecutive quarters. The next DMTKQ earnings date is expected around September 1, 2026.
Each quarter, investors track DMTKQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DMTKQ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DMTKQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DMTKQ earnings · 4 questionsDermTech, Inc.'s next earnings report is expected around September 1, 2026. DMTKQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DMTKQ historically reports after market close (AMC).
DMTKQ earnings datewhen is DMTKQ earningsDMTKQ next earnings datewhen does DMTKQ report earningsDMTKQ earnings calendar
▸ Source: FMP · DermTech, Inc. SEC filings · US GAAP · DermTech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026